NCT04865770: An ongoing trial by Novo Nordisk A/S
This trial is ongoing. It must report results 3 weeks, 3 days ago.
Full data
| Full entry on ClinicalTrials.gov | NCT04865770 |
|---|---|
| Title | Renal Mode of Action of Semaglutide in Patients With Type 2 Diabetes and Chronic Kidney Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 28, 2021 |
| Completion date | Nov. 21, 2024 |
| Required reporting date | Nov. 21, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |